Fingerprint
Dive into the research topics of 'Tofacitinib, the First Oral Janus Kinase Inhibitor Approved for Adult Ulcerative Colitis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Tofacitinib, the First Oral Janus Kinase Inhibitor Approved for Adult Ulcerative Colitis
Brittany N. Palasik, Hongmei Wang
Research output: Contribution to journal › Review article › peer-review
1
Scopus
citations